587 related articles for article (PubMed ID: 18381443)
21. Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411.
Sharma VR; Thomas SD; Miller DM; Rezzoug F
Cancer Invest; 2018; 36(9-10):475-491. PubMed ID: 30396283
[TBL] [Abstract][Full Text] [Related]
22. Nucleolin antisense oligodeoxynucleotides induce apoptosis and may be used as a potential drug for nasopharyngeal carcinoma therapy.
Wu CD; Chou HW; Kuo YS; Lu RM; Hwang YC; Wu HC; Lin CT
Oncol Rep; 2012 Jan; 27(1):94-100. PubMed ID: 21956494
[TBL] [Abstract][Full Text] [Related]
23. AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia.
Mongelard F; Bouvet P
Curr Opin Mol Ther; 2010 Feb; 12(1):107-14. PubMed ID: 20140822
[TBL] [Abstract][Full Text] [Related]
24. [Apoptosis increased by bcl-2 antisense ODN in MCF-7 cell line].
Zheng J; Yao Z
Zhonghua Wai Ke Za Zhi; 1999 Jul; 37(7):418-20. PubMed ID: 11829877
[TBL] [Abstract][Full Text] [Related]
25. Aptamer-nanoparticle bioconjugates enhance intracellular delivery of vinorelbine to breast cancer cells.
Zhou W; Zhou Y; Wu J; Liu Z; Zhao H; Liu J; Ding J
J Drug Target; 2014 Jan; 22(1):57-66. PubMed ID: 24156476
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
Thomadaki H; Scorilas A
Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
[TBL] [Abstract][Full Text] [Related]
27. AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin.
Teng Y; Girvan AC; Casson LK; Pierce WM; Qian M; Thomas SD; Bates PJ
Cancer Res; 2007 Nov; 67(21):10491-500. PubMed ID: 17974993
[TBL] [Abstract][Full Text] [Related]
28. Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells.
Soundararajan S; Wang L; Sridharan V; Chen W; Courtenay-Luck N; Jones D; Spicer EK; Fernandes DJ
Mol Pharmacol; 2009 Nov; 76(5):984-91. PubMed ID: 19657047
[TBL] [Abstract][Full Text] [Related]
29. [The inhibitory effect of bcl-2 antisense oligodeoxynucleotide/RNA on the growth of cervical carcinoma in vitro].
Mi R; Wang H; Qu Q
Zhonghua Fu Chan Ke Za Zhi; 2000 Feb; 35(2):105-8. PubMed ID: 11809111
[TBL] [Abstract][Full Text] [Related]
30. Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation.
Reyes-Reyes EM; Šalipur FR; Shams M; Forsthoefel MK; Bates PJ
Mol Oncol; 2015 Aug; 9(7):1392-405. PubMed ID: 25911416
[TBL] [Abstract][Full Text] [Related]
31. Aptamer-based Targeted Delivery of a G-quadruplex Ligand in Cervical Cancer Cells.
Carvalho J; Paiva A; Cabral Campello MP; Paulo A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Sci Rep; 2019 May; 9(1):7945. PubMed ID: 31138870
[TBL] [Abstract][Full Text] [Related]
32. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
Han G; Fan B; Zhang Y; Zhou X; Wang Y; Dong H; Wei Y; Sun S; Hu M; Zhang J; Wei L
Oncol Rep; 2008 Oct; 20(4):929-39. PubMed ID: 18813837
[TBL] [Abstract][Full Text] [Related]
33. AS1411-conjugated gold nanoparticles affect cell proliferation through a mechanism that seems independent of nucleolin.
Kabirian-Dehkordi S; Chalabi-Dchar M; Mertani HC; Le Guellec D; Verrier B; Diaz JJ; Mehrgardi MA; Bouvet P
Nanomedicine; 2019 Oct; 21():102060. PubMed ID: 31336175
[TBL] [Abstract][Full Text] [Related]
34. Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas.
Li L; Hou J; Liu X; Guo Y; Wu Y; Zhang L; Yang Z
Biomaterials; 2014 Apr; 35(12):3840-50. PubMed ID: 24486214
[TBL] [Abstract][Full Text] [Related]
35. Calycosin stimulates proliferation of estrogen receptor-positive human breast cancer cells through downregulation of Bax gene expression and upregulation of Bcl-2 gene expression at low concentrations.
Chen J; Xiong WB; Xiong Y; Wu YY; Chen XJ; Shao ZJ; Liu LT; Kuang WJ; Tan XS; Zhou LM
JPEN J Parenter Enteral Nutr; 2011 Nov; 35(6):763-9. PubMed ID: 21799188
[TBL] [Abstract][Full Text] [Related]
36. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells.
Yang DC; Jiang X; Elliott RL; Head JF
Anticancer Res; 2002; 22(3):1513-24. PubMed ID: 12168831
[TBL] [Abstract][Full Text] [Related]
37. Apoptosis is associated with modifications of bcl-2 mRNA AU-binding proteins.
Donnini M; Lapucci A; Papucci L; Witort E; Tempestini A; Brewer G; Bevilacqua A; Nicolin A; Capaccioli S; Schiavone N
Biochem Biophys Res Commun; 2001 Oct; 287(5):1063-9. PubMed ID: 11587529
[TBL] [Abstract][Full Text] [Related]
38. Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancer.
Wolfson E; Solomon S; Schmukler E; Goldshmit Y; Pinkas-Kramarski R
Cell Death Dis; 2018 Jan; 9(2):47. PubMed ID: 29352243
[TBL] [Abstract][Full Text] [Related]
39. Modified AS1411 Aptamer Suppresses Hepatocellular Carcinoma by Up-Regulating Galectin-14.
Cho Y; Lee YB; Lee JH; Lee DH; Cho EJ; Yu SJ; Kim YJ; Kim JI; Im JH; Lee JH; Oh EJ; Yoon JH
PLoS One; 2016; 11(8):e0160822. PubMed ID: 27494117
[TBL] [Abstract][Full Text] [Related]
40. Tumor targeting with a (99m)Tc-labeled AS1411 aptamer in prostate tumor cells.
Noaparast Z; Hosseinimehr SJ; Piramoon M; Abedi SM
J Drug Target; 2015; 23(6):497-505. PubMed ID: 25673264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]